Compare Johnson & Johnson (JNJ) vs T-Rex 2X Long MSTR Daily Target ETF (MSTU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs T-Rex 2X Long MSTR Daily Target ETF — how do they compare? Johnson & Johnson trades at $261.41 (market cap $618.09B), while T-Rex 2X Long MSTR Daily Target ETF trades at $39.9 (market cap $809.00M). The key difference: Johnson & Johnson is far larger — about 764× T-Rex 2X Long MSTR Daily Target ETF's market cap, and Johnson & Johnson pays a 2.09% dividend while T-Rex 2X Long MSTR Daily Target ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and T-Rex 2X Long MSTR Daily Target ETF for 18 Days on average.
| JNJ | MSTU | |
|---|---|---|
Market Cap | $618.09B | $809.00M |
Volume | 6,050,983 | 4,577,465 |
Sector | Health | Leveraged / Inverse |
52-Week High | $278.43 | $451.00 |
52-Week Low | $186.00 | $14.60 |
Typical Hold Time | 129 Days | 18 Days |
Enterprise Value | $646.37B | — |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.
JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.
MSTU trades at $39.70, up 0.63% with bearish technical indicators showing 8 buy vs 13 sell signals. The stock faces resistance at $40-$43 with support at $37-$33. Recent corporate actions include a 10:1 reverse stock split effective August 24, 2026, and a $0.29 dividend declaration for H2-2026. Trading activity remains elevated as investors seek leveraged exposure to the underlying company.
The outlook remains cautious with technical weakness outweighing neutral oscillators. Key risks include the leveraged ETF structure's daily rebalancing effects and dependence on underlying stock volatility. Investment appeal hinges on continued institutional interest in the strategy exposure, though the bearish technical setup suggests near-term pressure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About T-Rex 2X Long MSTR Daily Target ETF
MSTU is a leveraged ETF that seeks daily investment results corresponding to 200% of the daily performance of the MicroStrategy Incorporated (MSTR) stock. It is designed as a tactical tool for experienced traders to take a bullish (long) position in MSTR, a company known for its significant Bitcoin holdings. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on MSTU →
